
United States · Research startup
Sentieon is a bioinformatics software company founded in July 2014 and based in Mountain View, California.
Funding reportedLast round: Series B
Sentieon is a bioinformatics software company founded in July 2014 and based in Mountain View, California.
The company specializes in developing high-performance, cloud-ready tools for genomic data analysis, aiming to provide precision data for precision medicine. Sentieon focuses on secondary analysis solutions for next-generation sequencing (NGS) data, offering accelerated and scalable pipelines that enhance standard tools while ensuring compatibility with existing workflows. The company’s product suite includes the DNAscope pipeline and related tools, which support both short-read and long-read sequencing data. Sentieon’s software is designed to be easily deployable and can operate on both cloud and on-premises environments. Its algorithms are optimized for CPU and ARM architectures, delivering faster processing times and lower compute costs. Sentieon’s solutions are utilized across healthcare, life sciences, and genomics, supporting research and clinical applications, including large-cohort joint calling for population-scale genomics.
Funding, as reported
What they build
Known for
health careliquid biopsylong-read variant callinggoogle cloud compatibilitybioinformatics softwaremolecular diagnosticsbiotechnology researchenterprisescopy number variationclinical genomicsultra-deep sequencingmulti-platform supportinformation technology & servicesrna sequencingcloud computingenterprise software
Built with from their website
Google MapsAdobeGoogle Tag Managerparallax.jsWordPress.orgDataTablesFont AwesomeApacheON24Viewport Meta
Element UIHostgatorAdobe Experience ManagerFacebook SDKUnderscore.jsOWL CarouselPriority HintsGoogle Font API
Add your raise, your deck and your story, and put Sentieon in front of investors. Or tell us what we have wrong.